Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-09

FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved Aurobindo Pharma's original ANDA for a generic combination of ipratropium bromide and albuterol sulfate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (ipratropium bromide and albuterol sulfate)

Snippet

ORIG AP for IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE)